Blood Diseases

Department of Health written question – answered at on 4 July 2016.

Alert me about debates like this

Photo of Diane Abbott Diane Abbott Shadow Secretary of State for Health

To ask the Secretary of State for Health, what the (a) treatment targets and (b) care processes are for people with (i) sickle cell disease and (ii) thalassaemia in each (A) clinical commissioning group area, (B) trust area and (C) national sickle cell and thalassaemia centre area in the most recent year for which figures are available.

Photo of George Freeman George Freeman The Parliamentary Under-Secretary of State for Business, Innovation and Skills, The Parliamentary Under-Secretary of State for Health

NHS England has a published service specification for haemoglobinopathy which covers the requirements of commissioned services providing specialised services for patients with sickle cell disease or thalassaemia. The specification was developed by the Haemoglobinopathies Clinical Reference Group that covers Sickle Cell Disease, Thalassaemia and other very rare anaemias requiring lifelong transfusion and chelation. The specification reflects that although these are complex disorders they are often grouped together and managed by the same specialist team. It recognises that each condition will have distinct clinical manifestations and treatments.

Specialised services for haemoglobinopathy care B08/S/a:

https://www.england.nhs.uk/wp-content/uploads/2013/06/b08-speci-serv-haemo.pdf

Does this answer the above question?

Yes0 people think so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.